(Q46295115)
Statements
1 reference
Multicentric, randomized phase III trial of two different adjuvant chemotherapy regimens plus three versus twelve months of trastuzumab in patients with HER2- positive breast cancer (Short-HER Trial; NCT00629278). (English)
1 reference
1 reference
1 reference
1 reference
PierFranco Conte
1 reference
Valentina Guarneri
1 reference
Antonio Frassoldati
1 reference
Maurizio Belfiglio
1 reference
Annamaria Molino
1 reference
Stefano Cascinu
1 reference
Francesco Cognetti
1 reference
Angelo Di Leo
1 reference
Paolo Pronzato
1 reference
Lucio Crinó
1 reference
Biagio Agostara
1 reference
1 October 2008
1 reference
8
1 reference
5
1 reference
453-456
1 reference